PharmAla Issues Q2 Financial Statements and Grants Options
Summary
TORONTO, April 21, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ('PharmAla” or the 'Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company f...
Description
TORONTO, April 21, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ('PharmAla” or the 'Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company f...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source